|
TBC1D23 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.374600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.168000E-01 |
| Normal-vs-Stage2 |
4.884400E-02 |
| Normal-vs-Stage3 |
3.741200E-01 |
| Normal-vs-Stage4 |
1.042360E-01 |
| Stage1-vs-Stage2 |
4.073700E-02 |
| Stage1-vs-Stage3 |
3.584600E-01 |
| Stage1-vs-Stage4 |
7.762300E-02 |
| Stage2-vs-Stage3 |
2.152200E-01 |
| Stage2-vs-Stage4 |
5.503800E-01 |
| Stage3-vs-Stage4 |
4.443600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.092000E-01 |
| Normal-vs-AfricanAmerican |
9.520400E-01 |
| Normal-vs-Asian |
8.482200E-01 |
| Caucasian-vs-AfricanAmerican |
5.234600E-01 |
| Caucasian-vs-Asian |
5.765800E-01 |
| AfricanAmerican-vs-Asian |
8.395800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.225800E-01 |
| Normal-vs-Female |
4.664600E-01 |
| Male-vs-Female |
8.858200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.210800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.376000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.618200E-02 |
| Normal-vs-Age(81-100Yrs) |
4.207200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.684300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.256600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.909990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.691000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.264800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.105600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.086600E-01 |
| Classical-VS-Follicular |
3.10839998185486E-09 |
| Classical-VS-Other |
5.582800E-01 |
| Classical-VS-Normal |
5.937000E-01 |
| Tall-VS-Follicular |
8.632100E-04 |
| Tall-VS-Other |
6.029200E-01 |
| Tall-VS-Normal |
7.797000E-01 |
| Follicular-VS-Other |
1.737990E-01 |
| Follicular-VS-Normal |
2.426000E-04 |
| Other-VS-Normal |
7.021200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.604300E-02 |
| Normal-vs-N1 |
5.129200E-01 |
| N0-vs-N1 |
2.558400E-01 |
|
|
